Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Treasury Shares (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Treasury Shares data on record, last reported at $10514.0 in Q4 2025.

  • For Q4 2025, Treasury Shares changed 0.0% year-over-year to $10514.0; the TTM value through Dec 2025 reached $10514.0, changed 0.0%, while the annual FY2025 figure was $10514.0, 0.0% changed from the prior year.
  • Treasury Shares reached $10514.0 in Q4 2025 per VRCA's latest filing, roughly flat from $10514.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $475000.0 in Q2 2021 and bottomed at $10514.0 in Q4 2023.
  • Average Treasury Shares over 5 years is $101777.6, with a median of $105144.0 recorded in 2021.
  • Peak YoY movement for Treasury Shares: skyrocketed 304.21% in 2022, then tumbled 97.53% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $105144.0 in 2021, then surged by 304.21% to $425000.0 in 2022, then crashed by 97.53% to $10514.0 in 2023, then changed by 0.0% to $10514.0 in 2024, then changed by 0.0% to $10514.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $10514.0 in Q4 2025, $10514.0 in Q3 2025, and $10514.0 in Q2 2025.